Netupitant/palonosetron
Appearance
Combination of | |
---|---|
Netupitant | NK1 receptor antagonist |
Palonosetron | 5-HT3 receptor antagonist |
Clinical data | |
Trade names | Akynzeo |
Netupitant/palonosetron (Akynzeo) is a fixed dose combination drug for prevention of acute and delayed nausea and vomiting associated with cancer chemotherapy.[1] Netupitant is an NK1 receptor antagonist and palonosetron is a 5-HT3 receptor antagonist.